YZYuhan Zhou

Yuhan Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuhan Zhou has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Alison Gartland

    The Mellanby Centre for Bone Research, The University of Sheffield, Sheffield, UK

    1 shared publication
  • Hector Arredondo Carrera

    The University of Sheffield, Oncology and Metabolism, Sheffield, United Kingdom

    1 shared publication
  • Huiqing Ge

    Department of Respiratory Care, Regional Medical Center for the National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou China

    1 shared publication
  • Huiyuan Liu

    Department of Chemical Engineering, Monash University, Clayton, Australia

    1 shared publication
  • Jianbang Su

    Department of Orthopaedics, Shengjing Hospital of China Medical University, Shenyang, China

    1 shared publication
  • Jiepei He

    The University of Sheffield, Oncology and Metabolism, Sheffield, United Kingdom

    1 shared publication

Latest Publications

  • Open Access

    Effects of Legacy PFAS and Novel Alternatives on Thyroid Function in Mother‒Child Populations: A Systematic Review

    by Lemin Gong, Yuhan Zhou

    Per‐ and polyfluoroalkyl substances (PFAS) are extensively utilized in industrial and consumer applications, such as firefighting foams, textiles, electronics, industrial coatings, food packaging, and household consumer products, due to their excellent chemical stability. However, legacy long‐chain PFAS are prohibited because of their endocrine‐disrupting properties, bioaccumulative nature, and potential carcinogenicity, followed by the emergence of new alternatives, such as short‐chain congeners and novel PFAS alternatives. PFAS are known to disrupt endocrine function, and the thyroid gland, a critical endocrine organ, is particularly vulnerable to their effects. Mother‒child populations are more likely to be affected by PFAS due to their specific physiological characteristics, metabolic differences, and developmental stages. This paper reviews the exposure levels of legacy PFAS and their alternatives in maternal and infant blood and breast milk, and the relationship between PFAS exposure and thyroid hormone (TH) levels. It also examines the similarities and differences in the mechanisms by which different PFAS affect thyroid function. Research has revealed that both legacy and PFAS alternatives have been detected in maternal blood, infant blood, and breast milk. While legacy PFAS exhibit higher exposure levels with notable regional variations, the concentrations of PFAS alternatives, although lower, remain a concern. PFAS exposure affects TH in mothers and infants, with legacy PFAS having a more significant effect. The mechanisms underlying thyroid disruption caused by different PFAS are largely similar. However, PFAS alternatives are characterized by high protein affinity, ability to disrupt fatty acid metabolism, and high hydrophilicity, and may also increase the risk of thyroid cancer (TC). This study provides critical evidence for evaluating the safety of PFAS alternatives and provides a scientific foundation for developing preventive and regulatory measures.


  • Ultra-processed food consumption, genetic susceptibility, and the risk of hip/knee osteoarthritis

    by Yingliang Wei, Tingjing Zhang, Yashu Liu, Huiyuan Liu, Yuhan Zhou, Jianbang Su, Liangkai Chen, Lunhao Bai, Yang Xia


  • Open Access

    Defining the role of P2X4 receptor in the prostate cancer bone metastasis

    by Jiepei He, Yuhan Zhou, Hector Arredondo Carrera, Ning Wang, Alison Gartland

  • Open Access

    Risk Factors for Patient–Ventilator Asynchrony and Its Impact on Clinical Outcomes: Analytics Based on Deep Learning Algorithm

    by Huiqing Ge, Kailiang Duan, Jimei Wang, Liuqing Jiang, Lingwei Zhang, Yuhan Zhou, Luping Fang, Leo M. A. Heunks, Qing Pan, Zhongheng Zhang

    Background and objectives: Patient–ventilator asynchronies (PVAs) are common in mechanically ventilated patients. However, the epidemiology of PVAs and its impact on clinical outcome remains controversial. The current study aims to evaluate the epidemiology and risk factors of PVAs and their impact on clinical outcomes using big data analytics.Methods: The study was conducted in a tertiary care hospital; all patients with mechanical ventilation from June to December 2019 were included for analysis. Negative binomial regression and distributed lag non-linear models (DLNM) were used to explore risk factors for PVAs. PVAs were included as a time-varying covariate into Cox regression models to investigate its influence on the hazard of mortality and ventilator-associated events (VAEs).Results: A total of 146 patients involving 50,124 h and 51,451,138 respiratory cycles were analyzed. The overall mortality rate was 15.6%. Double triggering was less likely to occur during day hours (RR: 0.88; 95% CI: 0.85–0.90; p < 0.001) and occurred most frequently in pressure control ventilation (PCV) mode (median: 3; IQR: 1–9 per hour). Ineffective effort was more likely to occur during day time (RR: 1.09; 95% CI: 1.05–1.13; p < 0.001), and occurred most frequently in PSV mode (median: 8; IQR: 2–29 per hour). The effect of sedatives and analgesics showed temporal patterns in DLNM. PVAs were not associated mortality and VAE in Cox regression models with time-varying covariates.Conclusions: Our study showed that counts of PVAs were significantly influenced by time of the day, ventilation mode, ventilation settings (e.g., tidal volume and plateau pressure), and sedatives and analgesics. However, PVAs were not associated with the hazard of VAE or mortality after adjusting for protective ventilation strategies such as tidal volume, plateau pressure, and positive end expiratory pressure (PEEP).